Common-Size Income Statement
Quarterly Data
Based on: 10-K (reporting date: 2026-06-28), 10-Q (reporting date: 2026-03-29), 10-Q (reporting date: 2025-12-28), 10-Q (reporting date: 2025-09-28), 10-K (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-Q (reporting date: 2024-12-29), 10-Q (reporting date: 2024-09-29), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-24), 10-Q (reporting date: 2023-09-24), 10-K (reporting date: 2023-06-25), 10-Q (reporting date: 2023-03-26), 10-Q (reporting date: 2022-12-25), 10-Q (reporting date: 2022-09-25), 10-K (reporting date: 2022-06-26), 10-Q (reporting date: 2022-03-27), 10-Q (reporting date: 2021-12-26), 10-Q (reporting date: 2021-09-26), 10-K (reporting date: 2021-06-27), 10-Q (reporting date: 2021-03-28), 10-Q (reporting date: 2020-12-27), 10-Q (reporting date: 2020-09-27).
The financial performance over the analyzed period demonstrates a long-term expansion in profitability, characterized by improving gross margins and a significant increase in operating efficiency toward the end of the period. While there was a period of margin compression and increased restructuring costs between early 2023 and early 2024, the subsequent trajectory shows strong recovery and margin expansion across all primary income levels.
- Gross Profitability and Cost Structure
- Gross margins remained relatively stable between 44% and 48% from September 2020 through December 2022, before experiencing a notable decline to 41.49% in March 2023. This dip coincided with the introduction of restructuring charges within the cost of goods sold. Following this trough, a consistent upward trend is observed, with gross margins climbing to a peak of 51.75% by June 2026. This improvement is driven by a steady reduction in the cost of goods sold as a percentage of revenue, which fell from a high of 58.51% in March 2023 to 48.25% by the end of the period.
- Operating Expense Analysis
- Research and development (R&D) expenditures showed significant fluctuation, moving from roughly 9% to 11% of revenue in the early years to a peak of 13.50% in March 2024. This suggests a period of intensified investment in product development. Subsequently, R&D costs trended downward to 9.56% by June 2026. Selling, general, and administrative (SG&A) expenses remained more consistent, generally fluctuating between 4% and 6%, indicating tight control over overhead costs. Total operating expenses peaked at 19.60% in March 2024 before receding to 14.36% by June 2026.
- Operating and Net Income Trends
- Operating income margins exhibit a strong recovery and growth pattern. After a decline to 24.35% in March 2023, the margin expanded steadily, reaching 37.39% by June 2026. This suggests significant operating leverage as revenue growth outpaced the growth of operating expenses. Net income margins followed a similar trajectory, starting at 25.92% in September 2020 and ending at 33.88% in June 2026. A notable spike in net margin to 33.26% occurred in June 2025, primarily influenced by a significant decrease in the income tax expense ratio to 1.14% during that specific quarter.
AI Ask an analyst for more